美国生物类似药的注册审批政策
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Regulatory approval pathway for biosimilars in the United States
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
